Open Access Highly Accessed Open Badges Research article

The effect of an intracerebroventricular injection of metformin or AICAR on the plasma concentrations of melatonin in the ewe: potential involvement of AMPK?

Jean-Baptiste Menassol1234*, Claire Tautou1234, Armelle Collet234, Didier Chesneau234, Didier Lomet1234, Joëlle Dupont1234, Benoît Malpaux1234 and Rex J Scaramuzzi12345

Author affiliations

1 Physiologie de la Reproduction et des Comportements UMR85, INRA, Nouzilly F-37380, France

2 Physiologie de la Reproduction et des Comportements UMR6175, INRA, Nouzilly F-37380, France

3 Université François Rabelais de Tours, Tours F-37041, France

4 IFCE, Nouzilly F-37380, France

5 Department of Veterinary Basic Sciences, Royal Veterinary College, Herts, UK

For all author emails, please log on.

Citation and License

BMC Neuroscience 2011, 12:76  doi:10.1186/1471-2202-12-76

Published: 29 July 2011



It is now widely accepted that AMP-activated protein kinase (AMPK) is a critical regulator of energy homeostasis. Recently, it has been shown to regulate circadian clocks. In seasonal breeding species such as sheep, the circadian clock controls the secretion of an endogenous rhythm of melatonin and, as a consequence, is probably involved in the generation of seasonal rhythms of reproduction. Considering this, we identified the presence of the subunits of AMPK in different hypothalamic nuclei involved in the pre- and post-pineal pathways that control seasonality of reproduction in the ewe and we investigated if the intracerebroventricular (i.c.v.) injection of two activators of AMPK, metformin and AICAR, affected the circadian rhythm of melatonin in ewes that were housed in constant darkness. In parallel the secretion of insulin was monitored as a peripheral metabolic marker. We also investigated the effects of i.c.v. AICAR on the phosphorylation of AMPK and acetyl-CoA carboxylase (ACC), a downstream target of AMPK, in brain structures along the photoneuroendocrine pathway to the pineal gland.


All the subunits of AMPK that we studied were identified in all brain areas that were dissected but with some differences in their level of expression among structures. Metformin and AICAR both reduced (p < 0.001 and p < 0.01 respectively) the amplitude of the circadian rhythm of melatonin secretion independently of insulin secretion. The i.c.v. injection of AICAR only tended (p = 0.1) to increase the levels of phosphorylated AMPK in the paraventricular nucleus but significantly increased the levels of phosphorylated ACC in the paraventricular nucleus (p < 0.001) and in the pineal gland (p < 0.05).


Taken together, these results suggest a potential role for AMPK on the secretion of melatonin probably acting trough the paraventricular nucleus and/or directly in the pineal gland. We conclude that AMPK may act as a metabolic cue to modulate the rhythm of melatonin secretion.